Case files from Stanford University Medical Center: ten years of HAART: a long wait for full HIV suppression.
作者信息
Shulman Nancy, Shafer Robert W
机构信息
Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California, USA.
出版信息
MedGenMed. 2007 Jan 16;9(1):10.
Abstract
摘要
相似文献
1
2
[Antiretroviral therapy in 2004].[2004年的抗逆转录病毒疗法]
MMW Fortschr Med. 2004 Apr 26;146 Spec No 1:46-8, 50-1.
3
HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors.以病毒进入抑制剂为重点的HIV/AIDS发病机制及治疗选择
Expert Rev Anti Infect Ther. 2006 Apr;4(2):303-12. doi: 10.1586/14787210.4.2.303.
4
Managing HIV/AIDS patients.管理艾滋病毒/艾滋病患者。
N J Med. 1998 May;95(5):55-60.
5
Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.接受高效抗逆转录病毒治疗的HIV-1感染患者的脑血管缺血事件：发病率及危险因素
Cerebrovasc Dis. 2009;27(6):559-63. doi: 10.1159/000214219. Epub 2009 Apr 24.
6
Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.持续通信：“非洲抗逆转录病毒疗法的推广会引发耐药性艾滋病毒的流行吗？”
AIDS. 2007 Jan 11;21(2):258-9; author reply 259-60. doi: 10.1097/QAD.0b013e32801121fb.
7
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.英国HIV协会2008年抗逆转录病毒疗法治疗HIV-1感染成人指南。
HIV Med. 2008 Oct;9(8):563-608. doi: 10.1111/j.1468-1293.2008.00636.x.
8
Regression of a cervical spinal mass following highly active antiretroviral therapy (HAART) in child with advanced human immunodeficiency virus (HIV) disease.
J Med Assoc Thai. 2007 Sep;90(9):1937-42.
9
German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004).德国-奥地利关于HIV感染抗逆转录病毒治疗的建议（2004年5月版）
Eur J Med Res. 2004 Nov 29;9(11):491-504.
10
HAART improves quality of life: should we care about the quality of spermatozoa?高效抗逆转录病毒疗法可改善生活质量：我们应该关注精子质量吗？
AIDS. 2008 Mar 12;22(5):647-8. doi: 10.1097/QAD.0b013e3282f4de4d.
本文引用的文献
1
Genotypic predictors of human immunodeficiency virus type 1 drug resistance.1型人类免疫缺陷病毒耐药性的基因型预测指标
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17355-60. doi: 10.1073/pnas.0607274103. Epub 2006 Oct 25.
2
Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen.gp41的基因进化揭示了在长期含恩夫韦肽挽救治疗方案下，gp41中密码子36、38和43之间存在高度排他性的关系。
AIDS. 2006 Oct 24;20(16):2075-80. doi: 10.1097/QAD.0b013e3280102377.
3
Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir.1型人类免疫缺陷病毒蛋白酶的基因型变化与对蛋白酶抑制剂替拉那韦的敏感性降低及病毒学反应相关。
J Virol. 2006 Nov;80(21):10794-801. doi: 10.1128/JVI.00712-06. Epub 2006 Aug 23.
4
Rapid emergence of enfuvirtide resistance in HIV-1-infected patients: results of a clonal analysis.HIV-1感染患者中恩夫韦肽耐药性的快速出现：克隆分析结果
J Acquir Immune Defic Syndr. 2006 Sep;43(1):60-4. doi: 10.1097/01.qai.0000234083.34161.55.
5
HIV type 1 fitness evolution in antiretroviral-experienced patients with sustained CD4+ T cell counts but persistent virologic failure.在接受抗逆转录病毒治疗且CD4 + T细胞计数持续稳定但病毒学持续失败的患者中，1型人类免疫缺陷病毒的适应性进化。
Clin Infect Dis. 2005 Sep 1;41(5):729-37. doi: 10.1086/432619. Epub 2005 Jul 22.
6
Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20).对恩夫韦肽（T-20）耐药的1型人类免疫缺陷病毒突变体的相对复制适应性
J Virol. 2004 May;78(9):4628-37. doi: 10.1128/jvi.78.9.4628-4637.2004.
7
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.在病毒血症可检测到的HIV感染患者中停用联合抗逆转录病毒药物治疗的病毒学和免疫学后果。
N Engl J Med. 2001 Feb 15;344(7):472-80. doi: 10.1056/NEJM200102153440702.
8
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.由联合抗逆转录病毒疗法导致的耐多药1型人类免疫缺陷病毒毒株。
J Virol. 1996 Feb;70(2):1086-90. doi: 10.1128/JVI.70.2.1086-1090.1996.
9
Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.在接受双脱氧核苷治疗的患者中出现对多种双脱氧核苷耐药的1型人类免疫缺陷病毒变体。
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2398-402. doi: 10.1073/pnas.92.6.2398.
Zotero 插件